Focusing on Antenatal corticosteroids (ANS)...

Antenatal corticosteroids (ANS) have been shown to reduce the risk of serious health problems and death among preterm infants - evidence suggests that ANS administration rates can and should be optimized to reach more than 90% of eligible pregnant women as a way to improve outcomes for babies born too soon.  

Our current focus is to ensure pregnant women between 24 weeks and 34 weeks of gestation who are at risk of preterm delivery within 7 days, receive a full course of corticosteroid treatment.  Teams will concentrate their efforts on developing guidelines for proper and timely administration of ANS and will devise PDSAs aimed at improving the patients understanding of why ANS treatment is beneficial and essential to the outcome of their baby.